Trial Registry Bill Should Request Protocol With Results, FDA’s Temple Says

Any proposal to expand the ClinicalTrials.gov registry that does not require submission of trial protocols "does not do the whole job," FDA Office of Medical Policy Director Robert Temple said at a June 19 session of the Drug Information Association in Atlanta